ABSTRACT T cells cultured at limit dilution for 8 days in a concanavalin A-stimulated, filler-cell and growth factor-supported system produced cytolytic clones with high efficiency. These clones were not specific, lysing a wide range of targets, syngeneic and allogeneic, of tumor and normal cell origin. Lysis was a cellmediated phenomenon but was not blocked by anti-Ly-2. One H-2-negative target-was lysed, but one was. resistant. Xenogeneic (human) tumor cells were not lysed. The cells in the clones were, large, vacuolated, granular lymphocytes. They originated from single Ly-2' responder cells and not from irradiated filler cells.
The culture system employed was designed. to measure the frequency of nonlytic CTL precursors by the limit-dilution approach (9, 10) . T cells, cultured at levels of about one cell per well, and stimulated with concanavalin A (Con A) in the presence of irradiated spleen filler cells and growth factors, grow rapidly for 9 days with a near-100% cloning efficiency (10) . With phytohemagglutinin (PHA) included to mediate lysis.of tumor target cells,, those clones. that are cytolytic may be detected, regardless of their specificity, in a radioautographic "'In-release assay (9, 11) .
Clones derived from,.Ly-2' T cells, but not those from Ly, 2-T cells, were cytolytic in this universal assay. The low cell input and strict linear fit to the zero-order Poisson relationship demonstrated the clonal nature of the response. The effector. cells were shown to be Thy-l+ derivatives of the responders rather than of the irradiated fillers (9) . It is the cells in such clones that we now show to have an unexpected LGL.morphology and to kill most.target cells, even-in the absence of lectin mediation.
MATERIALS AND METHODS
Mice. The 6-wk-old male inbred, specific pathogen-free strains used for responder and irradiated filler cells were CBA/ CaHWehi, C57BL/6J Wehi, and AKR/J Wehi.
Normal Targets. Macrophages were 6-day thioglycollate-induced peritoneal exudate cells. Activated T cells were obtained 3 days after culture of spleen cells (3 x 106 cells per ml) in RPMI medium with Con A (2 ,ug/ml); these cells are hereafter termed Con A blasts. In both cases viable light-density cells were selected by using a neutral pH density cut (12) Limit-Dilution Cultures..These are described in detail elsewhere (9, 10) . Spleen or lymph node cells were cultured in flatbottomed 96-well culture trays at 1-10 cells per well with 0.5 x 106 irradiated spleen filler cells in 0,2 ml of Hepes/RPMI medium containing Con A, 2-mercaptoethanol, fetal calf serum, and a supernatant from Con A-stimulated rat. spleen cultures. After 8 days almost all responder T cells had grown to form clones averaging 60,000 cells. Control cultures of filler cells alone contained mainly dead cells and debris after day 6.
Bulk Harvest of Lytic Clones. Cells from wells scored as cytolytic on the basis of a test sample assay (or from all wells when sorted Ly-2' cells were cultured) were pooled. Dead or damaged cells (mainly fillers) were removed by using a neutral pH density cut (12) in mouse tonicity metrizamide medium (density, 1.091 g/cm3).
Bulk Mixed Lymphocyte Reaction (MLR) Cultures. Responder spleen cells (2 x 106) were cultured with mitomycin C-treated stimulator spleen cells (3 X 106) in 1.5 ml of RPMI medium containing fetal calf serum and 2-mercaptoethanol in 24-well Costar trays for 5 days.
Cytotoxic Assay. The semiautomated radioautographic "'Inrelease assay is described elsewhere (9, 11 The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
together with, when required, PHA-M (1:100) or a-methylmannoside (0.1 M). After centrifugation, the cells were incubated for 4 Lack of Blockage with Anti-Ly-2. Addition of monoclonal anti-Ly-2 to the assay caused no detectable decrease in direct cytolysis by cells in these clones, although it caused a marked decrease in allospecific lysis by MLR-derived CTL (Table 2) .
Lytic Efficiency. The cells harvested from the clones gave direct lysis of P815 even at low effector-to-target ratios (Fig. 2) . However, they were only 1/10th as efficient as allospecific, MLRgenerated CTL preparations.
Range of Target Cells Lysed. The high proportion of clones capable of direct cytolysis was not just a feature of P815 target cells (Table 3) . A range of tumor lines, including the murine NK target YAC, and the syngeneic tumors C1. 18 and R1, were all lysed with high frequency, although the degree of lysis was sometimes less than with P815. Likewise, there was a high frequency of clones lysing normal macrophages (syngeneic and al- Frequency values are calculated from the incidence at day 9 of positive cultures according to the zero-order term of the Poisson distribution (9, 10). Each value is from the pooled data of at least two experiments, each involving at least 288 cultures (except LiBr and HL60, in which the data were from one experiment involving 160 cultures). The frequency of Ly-2+ T cells in the CBA spleen cells was 0.11. logeneic) and Con A blasts (syngeneic and allogeneic), generally with less efficiency than the lysis of P815. Two HLA-human lines (including a preferred human NK target) and two HLA+ lines were also tested. Killing was negligible in the absence of PHA (Table 3) , but all four were lysed with about the same frequency as allogeneic targets in the presence of PHA.
Influence of Target Cell H-2 on Lysis. One surface H-2-negative variant target, R1 (TI?) (13), was lysed, although with lower frequency and extent than R1, the H-2-positive line of origin. The H-2-negative Krebs ascites line showed negligible lysis. However, this line was not killed, even in the presence of PHA, and may be a resistant target.
Morphology of Cells in Cytolytic Clones. The appearance of cells in the lytic clones was examined, initially by assaying samples of cultures for direct cytolysis at day 8 and then making smears of individual positive cultures at day 9. An alternative was to pool positive cultures, remove dead filler cells, and then prepare smears. Finally, the simplest approach was to grow sorted Ly-2' T cells at four cells per well, pool all cultures (most of which were positive), and remove damaged cells before smearing. All approaches gave the same result (Fig. 3) . The vast majority of cells were large-to medium-sized, vacuolated, and granulated, although the granules were generally larger than those found in LGL in vivo. Many such cells were in division. Control cultures of filler cells alone yielded only a few viable cells of very diverse morphological type.
Origin of Cells in the Cytolytic Clones. The majority of LGL in these clones appeared to come from the single responder T cell rather than from the filler cells, as assessed by using responders and fillers of differing Thy-i allotype. AKR responder cells grown on CBA fillers were as effective as the CBA on CBA combination in producing directly cytolytic clones. The cells in such clones were found to be 79% Thy-i. 1-positive and 7% Thy- 
DISCUSSION
The striking aspect of these findings is the high frequency with which individual mature Ly-2' T cells gave rise to clones of LGL with an ability to directly lyse most target cells in a nonspecific manner. This may be a consequence of a particularly effective "cocktail" of growth and differentiation factors produced by the Con A-stimulated filler cells in these cultures. These nonspecific clones appeared where we expected to find specific CTL. The exact relationship between CTL and these nonspecific LGL remains to be established, but clearly they both arise from the Ly-2' pool. The Ly-2' population might include separate CTL Further study of the morphology, surface markers, and specificity potential of cells in these clones may clarify this point. These findings complicate interpretations of limit-dilution CTL-clone specificity analyses. A culture scored positive for cytolysis of a given target might be composed of specific CTL but might also include polyspecific LGL, depending on conditions. Several experiments suggesting generation of CTL specificity diversity in clones derived from pre-T or stem cells (14, 15 ) must now be reassessed, because the culture conditions may well have generated nonspecific LGL.
What is the basis of the nonspecific lysis by these clones? We have not yet completely excluded the possibility that the actual killing is done by a minor, filler cell-derived element merely activated by the LGL, but this seems unlikely in view of the extent of lysis. Target cell major histocompatibility antigen does not appear to be essential because the major histocompatibility complex-negative line RI (TL) was also killed. Generation of a range of specificity variants of a normal T-cell receptor could explain the results, but again the extent of lysis argues against this. A new developmental step, from Ly-2' T cell to a NK-like LGL with a new "universal" receptor is one explanation although universal in this context does not include human cells. Another is that LGL represent an extremely differentiated and potent form of CTL, with such a high cytolytic potential that even a low-affinity, transient interaction with the target cell leads to a lethal hit. 
